Canada markets open in 4 hours 42 minutes

Claritas Pharmaceuticals, Inc. (CLAZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0001+0.0001 (+9,900.00%)
At close: 09:52AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
Total Revenue
0
0
0
Operating Expenses
Research Development
-
-2,055
5,790
Selling General and Administrative
1,570
1,871
3,661
Total Operating Expenses
-485
-184
9,451
Operating Income or Loss
485
184
-9,451
Interest Expense
768
225
209
Total Other Income/Expenses Net
-
-587
-16,128
Income Before Tax
-3,079
-674
-25,834
Income Tax Expense
-4,884
-4,884
-4,622
Income from Continuing Operations
1,805
4,210
-21,212
Net Income
-4,718
4,210
-21,212
Net Income available to common shareholders
-4,718
4,210
-21,212
Basic EPS
-0.13
0.16
-1.00
Diluted EPS
-0.13
0.16
-1.00
Basic Average Shares
30,967
26,691
22,441
Diluted Average Shares
30,967
26,691
22,441